{"id":"8dfbc25dfbd8","type":"article","url":"https://hartvaat.nl/2026/02/01/dertigjaars-cardiovasculair-risico-bij-vrouwen-naar-lipoproteine-a-drempelwaarde/","title":"Dertigjaars cardiovasculair risico bij vrouwen naar lipoproteïne(a)-drempelwaarden","title_en":"Thirty-Year Risk of Cardiovascular Disease Among Women According to Thresholds of Lipoprotein(a)","category":"cholesterol","category_label":"Cholesterol","professions":["cardioloog","huisarts","internist"],"tags":["biomarkers-cardiovasculair","diabetes-type-2","dyslipidemie","ezetimibe","hdl-cholesterol","ldl-cholesterol","lipide-aferese","lipoproteïne-a","lipoproteïne-a-therapeutisch-doel","menopauze","pelacarsen","statines","vrouwen"],"journal":"JAMA Cardiology","doi":"https://jamanetwork.com/journals/jamacardiology/fullarticle/2843429","source_url":"https://doi.org/https://jamanetwork.com/journals/jamacardiology/fullarticle/2843429","authors":[],"significance":7,"published":"2026-02-01","source_date":"2026-02-01","image":"","kennis":["https://hartvaat.nl/kennis/lipiden/lpa-meten-wanneer-waarom/","https://hartvaat.nl/kennis/lipiden/ldl-doelwaarden-risicostratificatie/"],"congress":"","summary_en":"This cohort study examined Lp(a) levels as 30-year predictors of cardiovascular risk in women, showing that clinically relevant thresholds identify women at substantially elevated long-term cardiovascular risk who may benefit from emerging Lp(a)-lowering therapies.","created":"2026-07-03T10:25:26Z","updated":"2026-07-03T13:24:51Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Cohortstudie naar klinische drempels en percentielen van lipoproteïne(a) als 30-jarige voorspellers van cardiovasculair risico bij deelneemsters aan de Women's Health Study.","abstract_original":"This cohort study examines clinical thresholds and percentiles of baseline lipoprotein(a) levels as 30-year determinants of cardiovascular risk among participants in the Women’s Health Study."}